Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4371935 | Experimental Parasitology | 2009 | 4 Pages |
Abstract
American trypanosomiasis (Chagas disease) continues to be a significant public health problem, and the therapeutic potential of current antichagasic agents (nifurtimox and benznidazole) is rather limited. Here we report on the antitrypanosomal effect of 1-methoxyspirobrassinol and other indole phytoalexins-secondary metabolites produced by Cruciferous plants. These compounds, that previously demonstrated antimicrobial and anticancer properties, displayed significant antiproliferative effects on intracellular amastigotes of Trypanosoma cruzi and may be prospective candidates for antichagasic drug design and development.
Related Topics
Life Sciences
Immunology and Microbiology
Parasitology
Authors
Roman Mezencev, Melina Galizzi, Peter Kutschy, Roberto Docampo,